Alberto Bardelli
机构: University of Torino and IFOM ETS
每年引用次数
引用次数
引用: 76,178
H-指数: 113
I10-指数 : 275
出版物: 567
Does early metastatic seeding occur in colorectal cancer
Alessandro Magrì , Alberto Bardelli
Nature Reviews Gastroenterology & Hepatology 16 ( 11) 651 -653
6
2019
PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.
Andrea Sartore-Bianchi , Miriam Martini , Francesca Molinari , Silvio Veronese
Cancer Research 69 ( 5) 1851 -1857
643
2009
Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes
Jeffrey J Wallin , Jane Guan , Kyle A Edgar , Wei Zhou
PLOS ONE 7 ( 5)
37
2012
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): A proof-of-concept, multicentre, open-label, phase 2 trial
Andrea Sartore-Bianchi , Livio Trusolino , Cosimo Martino , Katia Bencardino
Lancet Oncology 17 ( 6) 738 -746
776
2016
Trabectedin and Olaparib in Patients With Advanced and Non-Resectable Bone and Soft-Tissue Sarcomas (TOMAS): An Open-Label, Phase 1b Study From the Italian Sarcoma Group
Giovanni Grignani , Lorenzo D'Ambrosio , Ymera Pignochino , Emanuela Palmerini
Lancet Oncology 19 ( 10) 1360 -1371
19
2018
Integrating liquid biopsies into the management of cancer
Giulia Siravegna , Silvia Marsoni , Salvatore Siena , Alberto Bardelli
Nature Reviews Clinical Oncology 14 ( 9) 531 -548
1,444
2017
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
Conor A. Bradley , , Manuel Salto-Tellez , Pierre Laurent-Puig
Nature Reviews Clinical Oncology 14 ( 9) 562 -576
143
2017
Modeling Tumor Progression by the Sequential Introduction of Genetic Alterations into the Genome of Human Normal Cells
Davide Zecchin , Sabrina Arena , Miriam Martini , Francesco Sassi
Human Mutation 34 ( 2) 330 -337
5
2013
PIK3CA cancer mutations display gender and tissue specificity patterns.
Silvia Benvenuti , Milo Frattini , Sabrina Arena , Carlo Zanon
Human Mutation 29 ( 2) 284 -288
68
2008
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.
Fonnet E. Bleeker , Simona Lamba , Sieger Leenstra , Dirk Troost
Human Mutation 30 ( 1) 7 -11
457
2009
Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes.
Fonnet E. Bleeker , Simona Lamba , Monica Rodolfo , Aldo Scarpa
Human Mutation 30 ( 2)
38
2009
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.
Asha Balakrishnan , Junia Y. Penachioni , Simona Lamba , Fonnet E. Bleeker
Human Mutation 30 ( 8) 1167 -1174
32
2009
MET mutations in cancers of unknown primary origin (CUPs).
Giulia M. Stella , Silvia Benvenuti , Daniela Gramaglia , Aldo Scarpa
Human Mutation 32 ( 1) 44 -50
56
2011
High-dose Vitamin C enhances cancer immunotherapy
Maurizio D’Incalci , Massimo Zucchetti , Federica Di Nicolantonio , Alberto Bardelli
Science Translational Medicine 12 ( 532) 1 -13
36
2020
“Invasive-growth” signaling by the Met/HGF receptor: The hereditary renal carcinoma connection
Alberto Bardelli , Luisa Pugliese , Paolo M Comoglio
Biochimica et Biophysica Acta 1333 ( 3)
73
1997
BRAF V600E is a determinant of sensitivity to proteasome inhibitors
Davide Zecchin , Valentina Boscaro , Enzo Medico , Ludovic Barault
Molecular Cancer Therapeutics 12 ( 12) 2950 -2961
13
2013
Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance
Giulia Siravegna , Alberto Bardelli
Genome Biology 15 ( 8) 449 -449
64
2014
Abstract B33: The oligoclonal antibody MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancer cells harboring EGFR extracellular domain mutations
Sabrina Arena , Giulia Siravegna , Benedetta Mussolin , Jeffrey D. Kearns
Cancer Research 76
2016
Abstract CT263: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients: The PEGASUS trial
Elena Elez , Filippo Pietrantonio , Andrea Sartore-Bianchi , Clara Montagut
Cancer Research 80
2020
Abstract IA22: Clonal evolution and drug resistance in colorectal cancers: The EGFR-RAS signaling pathway
Alberto Bardelli
Cancer Research 77
2017